Clinical Trials
9 trialsNCT06305962 2026-02-19
177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors
Radiopharm Theranostics, Ltd
Phase EARLY_PHASE1 Recruiting
NCT05620342 2026-02-05
Autologous CAR T-Cells Targeting the GD2 Antigen for Lung Cancer
UNC Lineberger Comprehensive Cancer Center
Phase EARLY_PHASE1 Recruiting
NCT07246304 2025-11-24
TC-D101 Cell Therapy for Patients With DLL3-Positive SCLC
TCRCure Biopharma Ltd.
Phase EARLY_PHASE1 Recruiting
NCT05557708 2025-07-08
A Safety Study of 212Pb-Pentixather Radioligand Therapy
University of Iowa
Phase EARLY_PHASE1 Not yet recruiting
NCT07007325 2025-06-05
PASSIFLORE
Institut Cancerologie de l'Ouest
Phase EARLY_PHASE1 Not yet recruiting
NCT06747832 2024-12-24
iNK-SCLC
Guangzhou Ruixin Biotechnological Co., LTD
Phase EARLY_PHASE1 Enrolling by invitation
NCT05886075 2023-06-02
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors
Shanghai Yunying Medical Technology
Phase EARLY_PHASE1 Unknown
NCT00499733 2019-01-18
Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase EARLY_PHASE1 Terminated
NCT00253461 2012-03-20
11C Topotecan PET Imaging
Case Comprehensive Cancer Center
Phase EARLY_PHASE1 Terminated